Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits

Experimental Neurology

Volumn 163, Issue 2, 2000, Pages 440-451

  Verwer, Ronald W H ^a   Jansen, Karen A ^a   Sluiter, Arja A ^a   Pool, Chris W ^a   Kamphorst, Wouter ^a   Swaab, Dick F ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Alzheimer's disease; apoE; ATP synthase; Cytochrome oxidase; Hippocampus; Immunocytochemistry; Metabolism

Indexed keywords

CYTOCHROME C OXIDASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CELL DEATH; ENZYME ACTIVITY; ENZYME SUBUNIT; GLUCOSE METABOLISM; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METABOLIC REGULATION; NEUROPIL; PRIORITY JOURNAL;

EID: 0034116863     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7385     Document Type: Article

References (53)

1. Blass J. P., Gibson G. E. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. 147:1991;513-525.
2. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., de Leon M. J., Miller D. C., Wisniewski H. M. Relationships between regional neuronal loss and duration and severity of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;414-420.
3. Bonte F. J., Weiner M. F., Bigio E. H., White C. L. III. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology. 202:1997;793-797.
4. Bozner P., Grishko V., Ledoux S. P., Wilson G. L., Chyan Y. C., Pappolla M. A. The amyloid beta protein induces oxidative damage of mitochondrial DNA. J. Neuropathol. Exp. Neurol. 56:1997;1356-1362.
5. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. (Suppl.). 165:1996;3-12.
6. Capaldi R. A. Structure and assembly of cytochrome c oxidase. Arch. Biochem. Biophys. 280:1990;252-262.
7. Chagnon P., Bétard C., Robitaille Y., Cholette A., Gauvreau D. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport. 6:1995;711-715.
8. Chandrasekaran K., Giordano T., Brady D. R., Stoll J., Martin L. J., Rapoport S. I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer's disease. Mol. Brain Res. 24:1994;336-340.
9. Chandrasekaran K., Hatanpää K., Rapoport S. I., Brady D. R. Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. Mol. Brain Res. 44:1997;99-104.
10. Chandrasekaran K., Hatanpää K., Brady D. R., Stoll J., Rapoport S. I. Downregulation of oxidative phosphorylation in Alzheimer disease: Loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Brain Res. 769:1998;13-19.
11. Chariot P., Ruet E., Authier F. J., Labes D., Poron F., Gherardi R. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathol. 91:1996;530-536.
12. Conover, W. J, 1980, Practical Nonparametric Statistics. 2nd ed, Wiley, New York.
13. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
14. Corder E. H., Jelic V., Basun H., Lannfelt L., Valind S., Winblad B., Nordberg A. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch. Neurol. 54:1997;273-277.
15. Craft S., Zallen G., Baker L. D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsych. 14:1992;253-267.
16. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging. 17:1996;123-130.
17. Darriet D., Der T., Collins R. C. Distribution of cytochrome oxidase in rat brain: Studies with diaminobenzidine histochemistry in vitro and [14C]cyanide tissue labeling in vivo. J. Cereb. Blood Flow Metab. 6:1986;8-14.
18. Foster N. L., Chase T. N., Mansi L., Brooks R., Fedio P., Patronas N. J., Di G. Cortical abnormalities in Alzheimer's disease. Ann. Neurol. 16:1984;649-654.
19. Gomez-Isla T., Price J. L., McKeel D. W. Jr., Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
20. Haxby J. V., Grady C. L., Koss E., Horwitz B., Schapiro M., Friedland R. P., Rapoport S. I. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology. 38:1988;1853-1863.
21. 1-antichiymotrypsin type A allele in Alzheimer's disease. Brain Imaging. 8:1997;2639-2643.
22. Hoogendijk W. J. G., Pool C. W., Troost D., Van Zwieten E., Swaab D. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain. 118:1995;131-143.
23. Hoyer S., Oestereich K., Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type. J. Neurol. 235:1988;143-148.
24. Kish S. J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L. J., Wilson J. M., DiStefano L. M., Nobrega J. N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
25. Liu S., Wong-Riley M. Nuclear-encoded mitochondrial precursor protein: Intramitochondrial delivery to dendrites and axon terminals of neurons and regulation by neuronal activity. J. Neurosci. 14:1994;5338-5351.
26. Liu S., Wong-Riley M. Disproportionate regulation of nuclear- and mitochondrial-encoded cytochrome oxidase subunit proteins by functional activity in neurons. Neuroscience. 67:1995;197-210.
27. Manning C. A., Ragozinno M. E., Gold P. E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol. Aging. 14:1993;523-528.
28. McKahnn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
29. Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C., Beal M. F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:1993;609-616.
30. Mielke R., Schröder R., Fink G. R., Kessler J., Herholz K., Heiss W. D. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol. 91:1996;174-179.
31. Mielke R., Zerres K., Uhlhaas S., Kessler J., Heiss W. D. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neurosci. Lett. 254:1998;49-52.
32. Mutisya E. M., Bowling A. C., Beal M. F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 1363:1994;2179-2181.
33. Nijtmans L. G. J., Spelbrink J. N., Van Galen M. J. M., Zwaan M., Klement J., Van den C. Expression and fate of the nuclearly encoded subunits of cytochrome-c oxidase in cultured human cells depleted of mitochondrial gene products. Biochim. Biophys. Acta. 1265:1995;117-126.
34. Parker W. D., Parks J., Filley C. M., Kleinschmidt-DeMasters B. K. Electron transport chain defects in Alzheimer's disease brain. Neurology. 44:1994;1090-1096.
35. Parker W. D., Parks J. K. Cytochrome oxidase in Alzheimer's disease brain: purification and characterization. Neurology. 45:1995;482-486.
36. Ravid R., Van Zwieten E., Swaab D. F. Brain banking and the human hypothalamus-factors to match for, pitfals and potentials. Progr. Brain Res. 93:1992;83-95.
37. Reiman E. M., Cassell R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein. E. New Engl. J. Med. 334:1996;752-758.
38. Reisberg B., Ferris S. H., De Leon M. J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 139:1982;1136-1139.
39. Salehi A., Lucassen P. J., Pool C. W., Ravid R., Gonatas N. K., Swaab D. F. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 59:1994;871-880.
40. Salehi A., Ravid R., Gonatas N. K., Swaab D. F. Decreased activity of neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 54:1995a;704-709.
41. Salehi A., Van de Nes J. A. P., Hofman M. A., Gonatas N. K., Swaab D. F. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res. 678:1995b;29-39.
42. Salehi A., Dubelaar E. J. G., Mulder M., Swaab D. F. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc. Natl. Acad. Sci. USA. 95:1998;11445-11449.
43. Seligman A. M., Karnovsky M. J., Wasserkrug H. L., Hanker J. S. Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell Biol. 38:1968;1-14.
44. Schapira A. H. V. Mitochondrial dysfunction in neurodegenerative disorders and aging. Schapira A. H. V., DiMauro S. Mitochondrial Disorders in Neurology. 1994;227-244 Butterworth and Heinemann, Oxford.
45. 0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. Eur. J. Biochem. 227:1995;916-921.
46. Simonian N. A., Hyman B. T. Functional alterations in Alzheimer's disease: Diminution of cytochrome oxidase in the hippocampal formation. J. Neuropathol. Exp. Neurol. 52:1993;580-585.
47. Simonian N. A., Hyman B. T. Functional alterations in Alzheimer's disease: Selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53:1994;508-512.
48. Small G. W., Mazziotta J. C., Collins M. T., Baxter L. R., Phelps M. E., Mandelkern M. A., Kaplan A., LaRue A., Adamson C. F., Chuang L., Guze B. H., Corder E. H., Saunders A. M., Haines J. L., Pericak-Vance M. A., Roses A. D. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. J. Am. Med. Assoc. 273:1995;942-947.
49. Taanman J. W., Burton M. D., Marusich M. F., Kennaway N. G., Capaldi R. A. Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochim. Biophys. Acta. 1315:1996;199-207.
50. Van Hoesen G. W., Hyman B. T. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Understanding the brain through the hippocampus. Storm-Mathisen J., Zimmer J., Ottersen O. P. Prog. Brain Res. 1990;445-457 Elsevier, Amsterdam.
51. West M. J., Coleman P. D., Flood D. G., Troncoso J. C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 344:1994;769-772.
52. Wong-Riley M. T. T. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci. 12:1989;94-101.
53. Wong-Riley M. T. T. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171:1979;11-28.